Show simple item record

dc.contributor.authorThorisdottir, Sigurveig
dc.contributor.authorJohannsson, Magnus
dc.contributor.authorOlafsdottir, Elin
dc.contributor.authorArnadottir, Margret
dc.date.accessioned2010-10-26T14:27:04Z
dc.date.available2010-10-26T14:27:04Z
dc.date.issued2009-04-01
dc.date.submitted2010-11-26
dc.identifier.citationBasic Clin. Pharmacol. Toxicol. 2009, 104 (4):273-5en
dc.identifier.issn1742-7843
dc.identifier.pmid19320635
dc.identifier.doi10.1111/j.1742-7843.2009.00376.x
dc.identifier.urihttp://hdl.handle.net/2336/113809
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractNo abstact
dc.language.isoenen
dc.relation.urlhttp://dx.doi.org/10.1111/j.1742-7843.2009.00376.xen
dc.subject.meshAdulten
dc.subject.meshApolipoproteins Ben
dc.subject.meshCholesterol, LDLen
dc.subject.meshCosyntropinen
dc.subject.meshDrug Administration Scheduleen
dc.subject.meshHormonesen
dc.subject.meshHumansen
dc.subject.meshInjections, Intramuscularen
dc.subject.meshMaleen
dc.subject.meshYoung Adulten
dc.titleSearch for the optimal dose interval of adrenocorticotrophic hormone (ACTH(1-24)) with regard to the lipid-lowering effecten
dc.typeArticleen
dc.identifier.journalBasic & clinical pharmacology & toxicologyen
html.description.abstractNo abstact


This item appears in the following Collection(s)

Show simple item record